Polymorphism at the ADH2 and ADH3 loci of alcohol dehydrogenase (ADH) has been shown to have an effect on the predisposition to alcoholism in Asian individuals. However, the results are not conclusive for white individuals. We have analyzed the ADH genotype of 876 white individuals from Spain (n ‫؍‬ 251), France (n ‫؍‬ 160), Germany (n ‫؍‬ 184), Sweden (n ‫؍‬ 88), and Poland (n ‫؍‬ 193). Peripheral blood samples from healthy controls and groups of patients with viral cirrhosis and alcohol-induced cirrhosis, as well as alcoholics with no liver disease, were collected on filter paper. Genotyping of the ADH2 and ADH3 loci was performed using polymerase chain reactionrestriction fragment length polymorphism methods on white cell DNA. In healthy controls, ADH2*2 frequencies ranged from 0% (France) to 5.4% (Spain), whereas ADH3*1 frequencies ranged from 47.6% (Germany) to 62.5% (Sweden). Statistically significant differences were not found, however, between controls from different countries, nor between patients with alcoholism and/or liver disease. When all individuals were grouped in nonalcoholics (n ‫؍‬ 451) and alcoholics (n ‫؍‬ 425), ADH2*2 frequency was higher in nonalcoholics (3.8%) than in alcoholics (1.3%) (P ‫؍‬ .0016), whereas the ADH3 alleles did not show differences. Linkage disequilibrium was found between ADH2 and ADH3, resulting in an association of the alleles ADH2*2 and ADH3*1, both coding for the most active enzymatic forms. In conclusion, the ADH2*2 allele decreases the risk for alcoholism, whereas the ADH2*2 and ADH3*1 alleles are found to be associated in the European population. (HEPATOLOGY 2000;31:984-989.)
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Ingested alcohol is mostly metabolized in the liver by the successive action of alcohol dehydrogenase (ADH) and aldehyde dehydrogenase (ALDH). Both enzymes exhibit genetic polymorphisms that influence the rate of conversion of ethanol to acetaldehyde, and of acetaldehyde to acetate. It has been consistently reported that ALDH2 is the most important alcohol-metabolizing gene affecting predisposition to alcoholism in Asian populations. The prevalence of the ALDH2*2 allele, which codes for a physiologically inactive mitochondrial ALDH form, is lower in alcoholics than in nonalcoholics. [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] However, this allele has not been found in white individuals. 21 Regarding ADH, polymorphism is detected at the ADH2 and ADH3 loci. Alleles of ADH2 found in whites and Asians are ADH2*1 and ADH2*2, which encode for the low activity (␤1) and high activity (␤2) subunits, respectively. The kcat values for the resulting dimeric isozymes are very different: 9.2 min Ϫ1 for ␤1␤1 and 400 min Ϫ1 for ␤2␤2. 22 The ADH2*2 frequency is much higher in Asians (60%-80%) than in whites (0%-10%). 21 ADH3 alleles are ADH3*1 and ADH3*2, which produce the ␥1 and ␥2 subunits. The ␥1␥1 isozyme (kcat ϭ 87 min Ϫ1 ) is moderately more active than the ␥2␥2 isozyme (kcat ϭ 35 min Ϫ1 ). 22 ADH3*1 frequency is about 50% to 60% in whites and higher than 90% in Asians. 3, 23 A low prevalence of ADH2*2 [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] 20, 24 and ADH3*1, 4, 5, 7, 12, [16] [17] [18] which encode for the highly active ␤2␤2 and ␥1␥1 isozymes, respectively, has been identified in alcoholic Asians, although some reports do not find differences in ADH3 polymorphism between alcoholic and nonalcoholic Asians. 6, 8 An explanation for both the ALDH and ADH allele distributions is that in each case, the enzymatic form resulting from the respective gene expression (ALDH2*2, ADH2*2, or ADH3*1) produces a higher concentration of acetaldehyde, either by a decreased oxidation rate to acetate or by a faster acetaldehyde production. A high acetaldehyde concentration results in uncomfortable symptoms that deter from excessive drinking. On the other hand, alcoholic individuals with the inactive ALDH2*2 or the highly active ADH2*2 or ADH3*1 may be at increased risk for organ damage. 25 Several reports in Asians partially support this concept. 7, 8, 14, 19, 24, 26, 27 In Asians, the high frequency of the ALDH2*2 genotype (10%-44%) 21 overshadows the effects of ADH variability. A study of the relationship between ADH polymorphism and alcohol-related diseases in Europeans would provide the opportunity for excluding the otherwise strong influence of ALDH deficiency. It would also be of interest to screen a population with personal and social attitudes toward alcohol that are different from those of the more studied Asian societies. However, the low prevalence of ADH2*2 in whites 3 has precluded until now the finding of a significant correlation between this allele and alcohol pathology in Europe, [28] [29] [30] [31] [32] although a relationship similar to that found in Asians has been recently reported for Jewish 33 and Australian 34 men. Moreover, except for some alcohol-related cancers, [35] [36] [37] no correlation 28, [30] [31] [32] 38, 39 or conclusive results 34, 40, 41 have been reported regarding the influence of the ADH3 gene on alcohol-related pathologies in whites. In the present report we have analyzed a large European sample with the objective of determining the distribution of the ADH alleles in different European countries and correlating the ADH polymorphism with alcoholism and alcohol-induced cirrhosis in whites.
MATERIALS AND METHODS

Subjects.
The study protocol was approved by the Ethical Committees of the 5 participating medical centers, and all patients gave written informed consent.
Genotyping was performed on blood from 876 white individuals, men and women, aged from 20 to 84 years, from the following populations: Tarragona (Spain), Bordeaux (France), Heidelberg (Germany), Stockholm (Sweden), and Krakó w (Poland). Immigrants and their descendants were excluded. Subjects were classified into 4 groups according to their alcohol intake and the presence of liver disease. Men who consumed more than 100 g of pure alcohol per day and women with a daily alcohol intake of more than 70 g, for more than 10 years, were considered alcoholics (n ϭ 425). They were all patients admitted to the hospital for alcohol detoxification and they fulfilled the diagnostic criteria for alcohol dependence. 42 Alcohol history was obtained by a face-to-face interview, and all these patients had a positive CAGE test. In doubtful cases, relatives were also interviewed. Alcoholics included patients with alcoholinduced cirrhosis and individuals with no liver disease. Patients with alcohol-induced pancreatitis were excluded. Nonalcoholic subjects (n ϭ 451) were individuals who consumed less than 40 g (men) or 20 g (women) of pure alcohol per day, and did not meet the criteria for alcohol dependence. 42 They included healthy controls and patients with viral cirrhosis. Cirrhosis, either of viral or alcoholic origin was diagnosed, in most cases, by means of histopathologic examination of a liver sample obtained by percutaneous needle biopsy. In 7 subjects from Tarragona and 20 from Krakó w, for whom biopsy was contraindicated (usually because of severe coagulation abnormalities), and in all patients from Stockholm, cirrhosis was established by clinical criteria: physical examination, liver function test, liver ultrasonography and, in most cases, demonstration of oesophageal varices through upper gastrointestinal endoscopy. Healthy controls were blood donors and hospital personnel with no history of alcoholism, no evidence of liver disease at physical examination, and normal liver function tests. Alcoholics with no liver disease met the alcoholism criteria mentioned above and had normal liver or minor nonspecific hepatic abnormalities at the above clinical analyses and, in some cases, at pathological examination of percutaneous needle biopsy of the liver. Biopsies in these individuals were performed for diagnostic purposes, usually because of the presence of an enlarged liver and/or abnormalities in liver function test (up to 2-fold the upper normal limit). Patients were excluded if they had serological evidence of previous hepatitis B, hepatitis C, or human immunodeficiency virus infection.
In 42 individuals (28 nonalcoholics and 7 alcoholics from Tarragona, and 7 alcoholics from Stockholm) only information regarding alcoholism was available, but data on the presence and type of liver disease were lacking or inconsistent. This subset of patients was included only in the calculations that related genotype and allele frequencies with alcoholism, but not in the calculations that related genotype and allele frequencies with liver disease. Genotype Determination. Venous blood was blotted onto 3-mm filter paper (Whatman, Maidston, UK), dried, and stored at room temperature. The polymerase chain reaction was used to amplify polymorphic portions of exon 3 of the ADH2 gene and of exon 8 of the ADH3 gene 43 with specific primers. 7, 44 Five-millimeter-diameter discs of the filter paper with the dried blood were placed directly in a 100 µL amplification mixture and overlaid with mineral oil. Genomic DNA was denatured by heating for 6 minutes at 96°C. Thermus aquaticus (Taq) DNA polymerase (Ecogen, Barcelona, Spain) (2.5 units) was added and used for 30 cycles of amplification (1 minute at 95°C, 45 seconds at 55°C, and 45 seconds at 72°C) in a thermal cycler (PTC-100, M.J. Research, Watertown, MA). For allele detection, aliquots of the amplified DNA products were digested with MaeIII for ADH2*2, or with SspI (Roche Diagnostics, Mannheim, Germany) for ADH3*1. Products of digestion were run on 14% polyacrylamide gels and stained with ethidium bromide.
Statistical Analysis. Variation in allele frequencies between samples was analyzed using exact tests for population differentiation by means of the population genetics software GENEPOP. 45 Fisher' s method 46 was used to obtain a single test of the aggregate populations after combining probabilities from tests of significance based on the independent samples. 2 goodness of fit tests were used to study agreement with Hardy-Weinberg expectations. Linkage disequilibria between ADH2 and ADH3 were estimated by means of the composite digenic disequilibrium coefficient ⌬ AB·
47,48
RESULTS
ADH2
Genotype. We compared allele frequencies of the distinct European populations using data only from healthy nonalcoholics ( Table 1 ). The genotype distribution of all groups studied fit the expected Hardy-Weinberg equilibrium. The ADH2*2 allele frequency ranged from 0% in Bordeaux to 5.4% in Tarragona, with an average of 2.2%. Exact tests for population differentiation did not detect statistically significant differences either when all populations were simultaneously compared (P ϭ .158) or when all possible pairs of populations were contrasted with each other. Nonsignificant differences were also observed when groups of the same pathology were compared for each European population.
We have also compared the allele frequencies of healthy controls and patients with alcoholism and/or liver disease within each population. In no cases were differences found to be significant (results not shown).
The lack of differences between the healthy controls (Table  1) suggests that allele frequencies at ADH2 are homogeneous across Europe (further supported by the analysis of the nonalcoholics, see below), and therefore, all data could be combined in a single table (Table 2 ). Individuals were grouped according to their pathology, irrespective of country of origin, and the allele frequencies were compared. When the whole sample was considered, a lower prevalence of ADH2*2 was observed in the groups of alcoholics with no liver disease and alcohol-induced cirrhosis. Differences were significant when these two groups were compared with the viral cirrhosis group ( Table 2 ). The ADH2*2 prevalence of the alcohol-induced cirrhosis group was similar to that of the alcoholics with no liver disease.
To test the influence of ADH2 alleles on alcoholism, independently of the liver pathology, we compared all the nonalcoholic individuals (healthy controls and viral cirrhosis) with the alcoholic group (alcoholics with cirrhosis and alcoholics with no liver disease). For all populations but Bordeaux, the nonalcoholics exhibited a consistently higher ADH2*2 frequency, statistically different (P ϭ .0016) from that of the alcoholics after grouping all samples (Table 3) . Although grouping is correct on statistical grounds, because no stratification is apparent, an overall test of the null hypothesis of no genotypic effects can also be accomplished combining significance values by Fisher' s method. 46 In this case, statistical significance (P ϭ .0490) is attained after excluding Bordeaux. Table 3 also shows a lack of difference in ADH2 allele frequencies between European populations when nonalcoholics (healthy controls plus viral cirrhosis) are considered, reinforcing the conclusion on the homogeneity of the studied populations regarding the ADH2 polymorphism, previously reached in the analysis of the healthy controls (Table 1) .
The ADH2 genotyping data are presented in Table 4 according to drinking habits and gender. In both men and women, the ADH2*2 frequency was higher in nonalcoholics than in alcoholics, reaching statistical significance in men but not in women (P ϭ .13).
ADH3 Genotype. Table 5 shows the ADH3 gene frequencies found in the 5 European countries studied, considering only healthy controls. The genotype distribution of all groups studied fit the expected Hardy-Weinberg equilibrium. As for the ADH2 gene, no differences were found in the allele distribution of ADH3. Therefore, the European population studied can be considered homogeneous also for the ADH3 polymorphism.
Differences in ADH3 allele distribution were also not significant when the control group was compared with the groups of patients with alcoholism and/or liver disease within each European population (data not shown). In Table 6 (4 top lines), data from all populations have been pooled and grouped according to the 4 defined categories. Also in this case, differences were not significant. Finally, individuals were grouped in alcoholics and nonalcoholics within each population, as previously performed for ADH2 (Table 3) , but in contrast with the ADH2 analysis, no differences were found regarding the ADH3 allele frequencies (not shown). When samples from all the study sites were combined, lack of differences was also observed between nonalcoholics and alcoholics (Table 6 , 2 bottom lines), although genotype frequencies were different. Because results of Table 2 show that ADH2 polymorphism correlates with alcoholism, we Table 2 , classified as nonalcoholics (n ϭ 28) and alcoholics (n ϭ 14), are included. Differences between populations within groups were not statistically significant. Combining probabilities (right column, excluding Bordeaux) from independent tests 46 : Ϫ2⌺ ln P ϭ 15.569; P (total) ϭ .049. Table 3 . *P ϭ .002 nonalcoholic men vs. alcoholic men. performed again the ADH3 statistical analysis after discarding all samples with the ADH2*2 genotype to avoid the influence of ADH2 polymorphism. However, even in this case, differences in allele frequencies were not significant (result not shown). Lack of differences was also found when the comparison between groups was separately performed for men (n ϭ 527) and women (n ϭ 349) (not shown).
The fact that the ADH2 and ADH3 genes are contiguous in chromosome 4q21-23 of the human genome 49 led us to investigate a possible association between the alleles of each locus. The digenic disequilibrium for all individuals analyzed (N ϭ 876, ⌬ AB ϭ Ϫ0.009; P ϭ .003), as well as for the nonalcoholic and for the alcoholic groups analyzed separately (Table 7) , clearly indicates that the ADH2*1 allele is strongly associated with ADH3*2 whereas ADH2*2 is associated with ADH3*1. This association is not caused by a statistical mixing of the 5 populations, unmasking a possible stratification, because the same trend was found in all of them, although statistical significance was only achieved for the Tarragona population where sample size was larger (data not shown).
DISCUSSION
We report here, for a large European sample, that ADH2*2 frequency is higher in nonalcoholics than in alcoholics. The low prevalence of the ADH2*2 allele in Europeans precludes finding significant differences when each population analyzed is considered separately, because of the relatively small size of the sample, either when considering only healthy controls (Table 1) or nonalcoholics (Table 3) . It should be noticed, however, that in the latter case a clear tendency towards a higher ADH2*2 frequency in nonalcoholics is present in 4 of the 5 populations studied (Table 3) . It is reasonable to assume that the same tendency would be found for the Bordeaux population if a larger sample was analyzed. The homogeneity of the studied populations regarding ADH2 polymorphism allows the grouping of the data from the 5 countries, considering a single European population. Then differences between groups are more clear (Table 2 ) and they become highly significant when we classify all samples into only two groups, alcoholic (n ϭ 425) and nonalcoholic (n ϭ 451) (Table 3) . ADH2*2 frequency for nonalcoholics is 2.9-fold that for alcoholic subjects. This result fully agrees with the well-proven higher ADH2*2 frequency in nonalcoholics of Asian populations compared with alcoholics (about 1.3-to 2-fold), [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] 20, 24 and it represents a strong support to the hypothesis that the ADH2*2 allele is a genetic factor that decreases the risk for alcoholism. Thus, despite profound differences in both the polymorphism of other genes of alcohol metabolism (ALDH2 and ADH3) and in the social habits towards alcohol, whites are influenced similarly as Asians by ADH2 polymorphism in regard to alcohol addiction. The recent reports of an association of the ADH2*2 allele with a reduced ethanol consumption in Jewish men 33 and Australian men of European origin 34 support the concept that the effect of ADH2 polymorphism on alcohol drinking behavior is general. However, it is obvious that only a relatively small number of Europeans will be protected against alcoholism by possessing ADH2*2 because of the low frequency of individuals with genotypes containing this allele (4.5% in the control group, Table 1 ).
When, in addition to the alcohol drinking habit, the gender of the individual is also considered, the higher frequency of ADH2*2 in nonalcoholics is consistently found in both men and women, although the differences are not significant in women. A similar result was reported in a study with Australians of European origin, and several possible causes were suggested, including metabolic differences between men and women, and sample selection. 34 In our case a strong tendency towards a lower ADH2*2 frequency in alcoholics (1.1%) is observed in women, suggesting that the lack of significance is only caused by the smaller number in the female group (Table 4) .
It is reasonable to assume that within alcoholics, individuals with the ADH2*2 allele will be at higher risk of developing alcohol-related organ damage, because of the accumulation of the highly toxic acetaldehyde. 25 However, our results do not support this hypothesis in regard to alcohol-induced cirrhosis. This group exhibits a similar ADH2*2 frequency as the group of alcoholics without liver disease. In Asians, with the exception of reports by one research group, 19, 24, 27 all other studies are consistent with our results and suggest a lack of relationship between ADH2 polymorphism and alcoholinduced cirrhosis. 7, 8, 14 The frequency of the ADH2*2 allele in healthy Europeans is low, with only 2.2% in a sample of 224 individuals. This result is consistent with previous reports on ADH2 genotyping in whites. 21 The ADH2*2 frequency found by genotyping is in several cases lower than the frequencies estimated by phenotyping experiments 3 suggesting that the phenotype technique, based on gel electrophoresis and pH analysis, sometimes overestimated the ADH2*2 prevalence. 29, 31 Comparison of ADH2 frequencies between populations NOTE. Nonalcoholics and alcoholics are as in Table 3 . Differences in allele frequencies between groups were not significant. *P ϭ .023. Distribution of genotype frequencies was different between nonalcoholics and alcoholics. Table 3 . The digenic disequilibrium coefficient (⌬ AB ) 48 is Ϫ0.0108 (P ϭ .028) for nonalcoholics and Ϫ0.0074 (P ϭ .031) for alcoholics.
from distinct European countries shows no statistical evidence towards a geographically heterogeneous distribution of the ADH2 alleles. It can be noticed, however, that a strong difference exists between two close areas, Tarragona and Bordeaux. This difference is consistent with data of previous independent research 29, 31, 32, 38, 39, 50 and, although not statistically significant with the present size of the sample (Tables 1  and 3) , it deserves further investigation.
The distribution of the ADH3 alleles is also homogeneous among the European populations, with global frequencies of 55.6% for ADH3*1 and 44.4% for ADH3*2, in agreement with previous reports. 20, 22, 30, 47 The allele frequencies are very similar for all groups: controls, patients with viral cirrhosis, alcoholics with cirrhosis, and alcoholics with no liver disease (Table 6 ). Therefore, ADH3 does not appear to play a causative role in the development of alcohol-induced cirrhosis, which is in accordance with a previous study. 39 Moreover, the fact that the allele frequencies are practically identical between the alcoholic and nonalcoholic individuals (Table 6) suggests that the influence of ADH3 polymorphism on predisposition to alcohol abuse is small, in agreement with most previous studies in Europeans. 28, [30] [31] [32] 38, 39 Although this result seems to contradict the conclusions reached on Asians, this may not be the case when linkage disequilibrium between ADH2 and ADH3 is considered (see below).
An important metabolic effect of the polymorphism at the ADH2 locus is expected for the large difference in activity between the isozymes encoded by ADH2. 21 However, no differences in the rate of alcohol elimination have been reported between individuals with the ADH2*1 and ADH2*2 alleles. 51, 52 In short, the basis for a protective effect of ADH2*2 against alcohol misuse (''the ADH effect''), 53 is still not clear. 20 An appealing hypothesis is a role of the extrahepatic ethanol metabolism because the ADH2 gene is expressed in many organs other than liver, such as the blood vessels. [54] [55] [56] Thus, although the total extrahepatic metabolism is small when compared with the liver contribution, the local ethanol oxidation may significantly influence the normal function of these tissues. This could be a basis for unpleasant symptoms after ethanol intake in individuals with the most active ADH2*2 allele. This would also explain the ethanolinduced cutaneous erythema in ADH2*2 subjects. 57 We have proven that the European population shows linkage disequilibrium between ADH2 and ADH3. The two most active alleles ADH2*2 and ADH3*1 are associated, therefore the probability that both alleles are simultaneously found in an individual is higher than in the case of random allele segregation. Evidence for this allele linkage has been found also in Asian populations 4, 20, 58 suggesting a general occurrence. Our results on allele frequencies in whites and many reports in Asians indicate that ADH2 polymorphism has a stronger influence than ADH3 polymorphism on the levels of alcohol intake. The ADH2*2 frequency is low in Europeans, therefore the effect of the allele linkage must be small on the ADH3 allele distribution between alcoholics and nonalcoholics, although it may contribute to the ADH3 genotype differences found between both groups in the present work (Table 6 ). In the Asians, with a high prevalence of ADH2*2, the effect of the linkage on the ADH3 distribution should be stronger. 58 Thus, the association with ADH2*2 could provide an explanation for the high frequency of ADH3*1 reported in nonalcoholic Asians. 4, 5, 7, 12, [16] [17] [18] In fact, when the linkage was considered no relationship was found between ADH3 and alcoholism in recent studies with a large number of Chinese individuals. 20, 58 Therefore, the influence of ADH3 on ethanol consumption appears to be minimal in both European and Asian populations.
In conclusion, our data indicate that individuals of geographically distant European countries exhibit similar allele frequencies of the alcohol dehydrogenase class I genes ADH2 and ADH3. Polymorphism at ADH3 has no effect on the propensity to alcoholism, whereas ADH2*2 decreases the risk of excessive alcohol intake, an effect now shown in Europe. Finally, the most active alleles ADH2*2 and ADH3*1 are associated in Europeans, a fact that should be taken into account when allele frequencies are correlated to alcoholism and alcohol-related disease.
